Hyperglycemia Global Clinical Trials Review, H2, 2011

GlobalData
October 11, 2011
90 Pages - SKU: GBDT6620490
Generalized Seizures Global Clinical Trials Review, H2, 2014
7/14/2014 | published by: GlobalData
Generalized Seizures Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Generalized Seizures Global Clinical Trials Review, H2, 2014 provides data on the Generalized Seizures clinical trial scenario. This report provides elemental information and data  |  read more...
USD 2,500
Hypoxic-Ischemic Encephalopathy Global Clinical Trials Review, H2, 2014
7/14/2014 | published by: GlobalData
Hypoxic-Ischemic Encephalopathy Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Hypoxic-Ischemic Encephalopathy Global Clinical Trials Review, H2, 2014 provides data on the Hypoxic-Ischemic Encephalopathy clinical trial scenario. This report provides elemental information and data  |  read more...
USD 2,500
Insomnia Global Clinical Trials Review, H2, 2014
7/14/2014 | published by: GlobalData
Insomnia Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Insomnia Global Clinical Trials Review, H2, 2014 provides data on the Insomnia clinical trial scenario. This report provides elemental information and data relating to the  |  read more...
USD 2,500
Neonatal Seizures Global Clinical Trials Review, H2, 2014
7/14/2014 | published by: GlobalData
Neonatal Seizures Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Neonatal Seizures Global Clinical Trials Review, H2, 2014 provides data on the Neonatal Seizures clinical trial scenario. This report provides elemental information and data  |  read more...
USD 2,500
Partial Seizure Global Clinical Trials Review, H2, 2014
7/14/2014 | published by: GlobalData
Partial Seizure Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Partial Seizure Global Clinical Trials Review, H2, 2014 provides data on the Partial Seizure clinical trial scenario. This report provides elemental information and data  |  read more...
USD 2,500
OpportunityAnalyzer: Cystic Fibrosis - Opportunity Analysis and Forecasts to 2018 - Event-Driven Update
7/7/2014 | published by: GlobalData
OpportunityAnalyzer: Cystic Fibrosis - Opportunity Analysis and Forecasts to 2018 - Event-Driven Update Summary Cystic Fibrosis (CF) is an autosomal recessive disease characterized by the secretion of thick, sticky mucus which clogs the lungs and leads to  |  read more...
USD 5,995
Follicular Lymphoma - Pipeline Review, H2 2014
7/15/2014 | published by: Global Markets Direct
Follicular Lymphoma - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Follicular Lymphoma - Pipeline Review, H2 2014’, provides an overview of the Follicular Lymphoma’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Follicular  |  read more...
USD 2,000
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) - Pipeline Review, H2 2014
7/15/2014 | published by: Global Markets Direct
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) - Pipeline Review, H2 2014’, provides an overview of the Peripheral Arterial  |  read more...
USD 2,000
Malignant Mesothelioma - Pipeline Review, H2 2014
7/15/2014 | published by: Global Markets Direct
Malignant Mesothelioma - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Malignant Mesothelioma - Pipeline Review, H2 2014’, provides an overview of the Malignant Mesothelioma’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Malignant  |  read more...
USD 2,000
Myocardial Infarction - Pipeline Review, H2 2014
7/15/2014 | published by: Global Markets Direct
Myocardial Infarction - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Myocardial Infarction - Pipeline Review, H2 2014’, provides an overview of the Myocardial Infarction’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Myocardial  |  read more...
USD 2,000
 

SELECT A LICENSE

    Online Download  USD 1,000  
    Global Site License  USD 3,000  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!